Tumoral melanosis associated with nivolumab therapy for metastatic melanoma

J Dtsch Dermatol Ges. 2022 Aug;20(8):1130-1131. doi: 10.1111/ddg.14809. Epub 2022 Jul 6.

Authors

Noelia Moreiras Arias¹, José Manuel Suárez Peñaranda², Laura Sainz Gaspar¹, Alexandra Cortegoso Mosquera³, Dolores Sánchez-Aguilar¹

Affiliations

¹ Department of Dermatology, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.
² Department of Pathology, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.
³ Department of Oncology, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.

PMID: 35792091
DOI: 10.1111/ddg.14809

No abstract available

Publication types

Letter

MeSH terms

Humans
Melanoma* / pathology
Melanosis* / complications
Nivolumab / adverse effects
Skin Neoplasms* / pathology

Substances

Nivolumab